Pulmonary and Critical Care Medicine

A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Critical Care".

Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 24775

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Via dei Vestini n 33, 66100 Chieti, Italy
Interests: lung ultrasound; cardiac ultrasound; diaphragm ultrasound; critical care medicine; mechanical ventilation; intensive care medicine; airway management; ventilation; cardiopulmonary resuscitation; resuscitation; sepsis; anesthesiology; emergency management
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Anesthesia and Intensive Care Unit, Department of Anesthesia and Intensive Care, Academic Hospital of Udine, 33100 Udine, Italy
Interests: nutrition in ICU; transcranial Doppler; intracranial pressure monitoring; traumatic brain injury; subarachnoid hemorrhage; ischemic stroke; decompressive craniotomy; invasive hemodynamic monitoring

Special Issue Information

Dear Colleagues,

After the COVID-19 pandemic, nothing will be identical in the critical care environment for ARDS patients’ management. As COVID-19 has changed our understanding of seeing patients with acute respiratory failure, this experience needs to be described by major experts in the field, and this is the scope of this Special Issue, which invites original research, short reports, and reviews from the real clinical world.

In that way, we think a thematic issue in Healthcare could capture a “picture” of the most commonly used approaches in critical care for the next generation of our medical students, residents, and physicians during this pandemic. 

Prof. Dr. Luigi Vetrugno
Dr. Cristian Deana
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lung ultrasound
  • cardiac ultrasound
  • COVID-19
  • SARS-CoV2
  • outcome
  • critically ill
  • ICU

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (10 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review, Other

5 pages, 463 KiB  
Editorial
COVID-19 Hurricane: Recovering the Worldwide Health System with the RE.RE.RE. (REsponse–REstoration–REengineering) Approach—Who Will Get There First?
by Luigi Vetrugno, Cristian Deana and Salvatore Maurizio Maggiore
Healthcare 2022, 10(4), 602; https://doi.org/10.3390/healthcare10040602 - 23 Mar 2022
Cited by 2 | Viewed by 1567
Abstract
In 2007, I was (LV) attending to a one-month period of my pediatric residency at the Children’s Hospital in New Orleans [...] Full article
(This article belongs to the Special Issue Pulmonary and Critical Care Medicine)
Show Figures

Figure 1

Research

Jump to: Editorial, Review, Other

13 pages, 1526 KiB  
Article
Quality of Life, Family Support, Spirometry, and 6-Minute Walking Distance Differences between COVID-19 and Non-COVID-19 Intensive Care Unit Patients in One Year Following Hospital Discharge
by Konstantina Avgeri, Konstantinos Mantzarlis, Effrosyni Gerovasileiou, Konstantina Deskata, Maria Chatzi, George Fotakopoulos, Markos Sgantzos, Vasiliki Tsolaki, Epaminondas Zakynthinos and Demosthenes Makris
Healthcare 2024, 12(10), 996; https://doi.org/10.3390/healthcare12100996 - 13 May 2024
Cited by 1 | Viewed by 895
Abstract
Background: Critically ill patients after Intensive Care Unit (ICU) discharge may present disability in their cognitive and physical functions. Objectives: To investigate the quality of life (QoL) of both COVID-19 and non-COVID-19 patients following ICU discharge, lung function, and physical performance of participants. [...] Read more.
Background: Critically ill patients after Intensive Care Unit (ICU) discharge may present disability in their cognitive and physical functions. Objectives: To investigate the quality of life (QoL) of both COVID-19 and non-COVID-19 patients following ICU discharge, lung function, and physical performance of participants. Methods: This study was prospective and conducted between 2020 and 2021 in the “X” hospital. If patients were Mechanically-Ventilated (MV) > 48 h, they were included. Results: Fifty COVID-19 and seventy-two non-COVID-19 participants were included in this study. The mean (SD) of the total SF-36 scores at COVID-19 patients at hospital discharge and 3 and 12 months were 46.5 (14.5), 68.6 (17.8), and 82.3 (8.9) (p < 0.05), while non-COVID-19 participants were 48.5 (12.1), 72.2 (9.9), and 82.7 (5.4) (p < 0.05). The forced expiratory volume in one second (FEV1) and 6-minute walking distance (6MWD) were assessed at 3 and 12 months and significantly improved over 12 months. Conclusion: The QoL of COVID-19 patients improved significantly over time as FEV1 and 6MWD. Full article
(This article belongs to the Special Issue Pulmonary and Critical Care Medicine)
Show Figures

Figure 1

12 pages, 916 KiB  
Article
Incidence and Determinants of Acute Kidney Injury after Prone Positioning in Severe COVID-19 Acute Respiratory Distress Syndrome
by Riccardo La Rosa, Benedetta Grechi, Riccardo Ragazzi, Valentina Alvisi, Giacomo Montanari, Elisabetta Marangoni, Carlo Alberto Volta, Savino Spadaro and Gaetano Scaramuzzo
Healthcare 2023, 11(21), 2903; https://doi.org/10.3390/healthcare11212903 - 4 Nov 2023
Cited by 2 | Viewed by 1304
Abstract
(1) Background: Acute kidney injury (AKI) is common among critically ill COVID-19 patients, but its temporal association with prone positioning (PP) is still unknown, and no data exist on the possibility of predicting PP-associated AKI from bedside clinical variables. (2) Methods: We analyzed [...] Read more.
(1) Background: Acute kidney injury (AKI) is common among critically ill COVID-19 patients, but its temporal association with prone positioning (PP) is still unknown, and no data exist on the possibility of predicting PP-associated AKI from bedside clinical variables. (2) Methods: We analyzed data from 93 COVID-19-related ARDS patients who underwent invasive mechanical ventilation (IMV) and at least one PP cycle. We collected hemodynamic variables, respiratory mechanics, and circulating biomarkers before, during, and after the first PP cycle. PP-associated AKI (PP-AKI) was defined as AKI diagnosed any time from the start of PP to 48 h after returning to the supine position. A t-test for independent samples was used to test for the differences between groups, while binomial logistical regression was performed to assess variables independently associated with PP-associated AKI. (3) Results: A total of 48/93 (52%) patients developed PP-AKI, with a median onset at 24 [13.5–44.5] hours after starting PP. No significant differences in demographic characteristics between groups were found. Before starting the first PP cycle, patients who developed PP-AKI had a significantly lower cumulative fluid balance (CFB), even when normalized for body weight (p = 0.006). Central venous pressure (CVP) values, measured before the first PP (OR 0.803, 95% CI [0.684–0.942], p = 0.007), as well as BMI (OR 1.153, 95% CI = [1.013–1.313], p = 0.031), were independently associated with the development of PP-AKI. In the multivariable regression analysis, a lower CVP before the first PP cycle was independently associated with ventilator-free days (OR 0.271, 95% CI [0.123–0.936], p = 0.011) and with ICU mortality (OR:0.831, 95% CI [0.699–0.989], p = 0.037). (4) Conclusions: Acute kidney injury occurs frequently in invasively ventilated severe COVID-19 ARDS patients undergoing their first prone positioning cycle. Higher BMI and lower CVP before PP are independently associated with the occurrence of AKI during prone positioning. Full article
(This article belongs to the Special Issue Pulmonary and Critical Care Medicine)
Show Figures

Figure 1

8 pages, 853 KiB  
Article
Thromboelastography Profile Is Associated with Lung Aeration Assessed by Point-of-Care Ultrasound in COVID-19 Critically Ill Patients: An Observational Retrospective Study
by Daniele Guerino Biasucci, Maria Grazia Bocci, Danilo Buonsenso, Luca Pisapia, Ludovica Maria Consalvo, Joel Vargas, Domenico Luca Grieco, Gennaro De Pascale and Massimo Antonelli
Healthcare 2022, 10(7), 1168; https://doi.org/10.3390/healthcare10071168 - 22 Jun 2022
Cited by 5 | Viewed by 1553
Abstract
Background. To evaluate relationships between lung aeration assessed by lung ultrasound (LUS) with viscoelastic profiles obtained by thromboelastography (TEG) in COVID-19 respiratory failure. Methods. Retrospective analysis in a tertiary ICU in Rome, Italy. Forty invasively ventilated adults with COVID-19 underwent LUS and TEG [...] Read more.
Background. To evaluate relationships between lung aeration assessed by lung ultrasound (LUS) with viscoelastic profiles obtained by thromboelastography (TEG) in COVID-19 respiratory failure. Methods. Retrospective analysis in a tertiary ICU in Rome, Italy. Forty invasively ventilated adults with COVID-19 underwent LUS and TEG assessment. A simplified LUS protocol consisting in scanning six areas, three per side, was adopted. A score from 0 to 3 was assigned to each area. TEG®6s was used to obtain viscoelastic hemostatic assay parameters which were compared to LUS score. Results. There was a significant inverse correlation between LUS score and static compliance of the respiratory system (Crs, rs −0.75; p < 0.001). We found a significant association between LUS and functional fibrinogen maximum amplitude (FF-MA): among 18 patients with LUS score ≤ 12, median FF-MA was 31 mm [IQR 28–39] whilst, among 22 patients with LUS score > 12, it was 46.3 mm [IQR 40–53], p = 0.0004. Median of the citrated recalcified kaolin-activated maximum amplitude (CK-MA) was 66.1 mm [64.4–68] in the LUS score ≤ 12 group, and 69.6 [68.5–70.7] when LUS score > 12, p < 0.002. Conclusions. The hypercoagulable profile as defined by elevated FF-MA and CK-MA may be associated with a low degree of lung aeration as assessed by LUS. Full article
(This article belongs to the Special Issue Pulmonary and Critical Care Medicine)
Show Figures

Figure 1

9 pages, 668 KiB  
Article
Can Lung Ultrasound Be the Ideal Monitoring Tool to Predict the Clinical Outcome of Mechanically Ventilated COVID-19 Patients? An Observational Study
by Luigi Vetrugno, Francesco Meroi, Daniele Orso, Natascia D’Andrea, Matteo Marin, Gianmaria Cammarota, Lisa Mattuzzi, Silvia Delrio, Davide Furlan, Jonathan Foschiani, Francesca Valent and Tiziana Bove
Healthcare 2022, 10(3), 568; https://doi.org/10.3390/healthcare10030568 - 18 Mar 2022
Cited by 13 | Viewed by 2074
Abstract
Background: During the COVID-19 pandemic, lung ultrasound (LUS) has been widely used since it can be performed at the patient’s bedside, does not produce ionizing radiation, and is sufficiently accurate. The LUS score allows for quantifying lung involvement; however, its clinical prognostic role [...] Read more.
Background: During the COVID-19 pandemic, lung ultrasound (LUS) has been widely used since it can be performed at the patient’s bedside, does not produce ionizing radiation, and is sufficiently accurate. The LUS score allows for quantifying lung involvement; however, its clinical prognostic role is still controversial. Methods: A retrospective observational study on 103 COVID-19 patients with respiratory failure that were assessed with an LUS score at intensive care unit (ICU) admission and discharge in a tertiary university COVID-19 referral center. Results: The deceased patients had a higher LUS score at admission than the survivors (25.7 vs. 23.5; p-value = 0.02; cut-off value of 25; Odds Ratio (OR) 1.1; Interquartile Range (IQR) 1.0−1.2). The predictive regression model shows that the value of LUSt0 (OR 1.1; IQR 1.0–1.3), age (OR 1.1; IQR 1.0−1.2), sex (OR 0.7; IQR 0.2−3.6), and days in spontaneous breathing (OR 0.2; IQR 0.1–0.5) predict the risk of death for COVID-19 patients (Area under the Curve (AUC) 0.92). Furthermore, the surviving patients showed a significantly lower difference between LUS scores at admission and discharge (mean difference of 1.75, p-value = 0.03). Conclusion: Upon entry into the ICU, the LUS score may play a prognostic role in COVID-19 patients with ARDS. Furthermore, employing the LUS score as a monitoring tool allows for evaluating the patients with a higher probability of survival. Full article
(This article belongs to the Special Issue Pulmonary and Critical Care Medicine)
Show Figures

Figure 1

11 pages, 778 KiB  
Article
Establishing a New ECMO Referral Center Using an ICU-Based Approach: A Feasibility and Safety Study
by Ryszard Gawda, Maciej Piwoda, Maciej Marszalski, Katarzyna Lyp, Jolanta Piwoda, Magdalena Maj, Maciej Gawor, Maciej Molsa, Marek Pietka and Tomasz Czarnik
Healthcare 2022, 10(3), 414; https://doi.org/10.3390/healthcare10030414 - 22 Feb 2022
Cited by 3 | Viewed by 3043
Abstract
Background: A high-volume center with a multidisciplinary team is regarded as the optimal place for providing extracorporeal membrane oxygenation (ECMO). We hypothesize that an ECMO center can also be successfully created and subsequently developed entirely by intensivists in a mid-size mixed intensive care [...] Read more.
Background: A high-volume center with a multidisciplinary team is regarded as the optimal place for providing extracorporeal membrane oxygenation (ECMO). We hypothesize that an ECMO center can also be successfully created and subsequently developed entirely by intensivists in a mid-size mixed intensive care unit (ICU). Methods: A model was created for setting up a new ECMO referral center within the structure of an existing mixed ICU in a tertiary hospital. A retrospective analysis was carried out of the first 33 patients treated in the initial period of the center’s activity, from mid 2018 to the end of 2020. Results: An ECMO center was established and developed entirely based on the resources of an existing mixed ICU. Thirty-three patients were treated. They had an overall survival rate at 90 days of 60.6%. In veno-venous (VV) mode ECMO duration, ICU length of stay, and SOFA score were significantly higher than in veno-arterial mode. No significant differences in clinical characteristics were observed between survivors and non-survivors on VV-ECMO. Conclusions: A regional ECMO center can be set up as an integral part of a mixed ICU in a tertiary hospital. Extracorporeal therapy, such as continuous renal replacement therapy and mechanical ventilation can be managed entirely by intensivists. Further studies are needed to show that the ICU-based approach to setting up a new ECMO center is no less effective than the multidisciplinary approach. Full article
(This article belongs to the Special Issue Pulmonary and Critical Care Medicine)
Show Figures

Figure 1

10 pages, 850 KiB  
Article
Timing to Intubation COVID-19 Patients: Can We Put It Off until Tomorrow?
by Júlio César Garcia de Alencar, Juliana Martes Sternlicht, Alicia Dudy Muller Veiga, Julio Flávio Meirelles Marchini, Juliana Carvalho Ferreira, Carlos Roberto Ribeiro de Carvalho, Izabel Marcilio, Katia Regina da Silva, Vilson Cobello Junior, Marcelo Consorti Felix, Luz Marina Gomez Gomez, Heraldo Possolo de Souza, Denis Deratani Mauá, Emergency USP COVID Group and HCFMUSP COVID-19 Study Group
Healthcare 2022, 10(2), 206; https://doi.org/10.3390/healthcare10020206 - 21 Jan 2022
Cited by 2 | Viewed by 3431
Abstract
Background: The decision to intubate COVID-19 patients receiving non-invasive respiratory support is challenging, requiring a fine balance between early intubation and risks of invasive mechanical ventilation versus the adverse effects of delaying intubation. This present study analyzes the association between intubation day and [...] Read more.
Background: The decision to intubate COVID-19 patients receiving non-invasive respiratory support is challenging, requiring a fine balance between early intubation and risks of invasive mechanical ventilation versus the adverse effects of delaying intubation. This present study analyzes the association between intubation day and mortality in COVID-19 patients. Methods: We performed a unicentric retrospective cohort study considering all COVID-19 patients consecutively admitted between March 2020 and August 2020 requiring invasive mechanical ventilation. The primary outcome was all-cause mortality within 28 days after intubation, and a Cox model was used to evaluate the effect of time from onset of symptoms to intubation in mortality. Results: A total of 592 (20%) patients of 3020 admitted with COVID-19 were intubated during study period, and 310 patients who were intubated deceased 28 days after intubation. Each additional day between the onset of symptoms and intubation was significantly associated with higher in-hospital death (adjusted hazard ratio, 1.018; 95% CI, 1.005–1.03). Conclusion: Among patients infected with SARS-CoV-2 who were intubated and mechanically ventilated, delaying intubation in the course of symptoms may be associated with higher mortality. Trial registration: The study protocol was approved by the local Ethics Committee (opinion number 3.990.817; CAAE: 30417520.0.0000.0068). Full article
(This article belongs to the Special Issue Pulmonary and Critical Care Medicine)
Show Figures

Figure 1

Review

Jump to: Editorial, Research, Other

9 pages, 450 KiB  
Review
Current Practice of High Flow through Nasal Cannula in Exacerbated COPD Patients
by Andrea Bruni, Eugenio Garofalo, Daniela Procopio, Silvia Corrado, Antonio Caroleo, Eugenio Biamonte, Corrado Pelaia and Federico Longhini
Healthcare 2022, 10(3), 536; https://doi.org/10.3390/healthcare10030536 - 15 Mar 2022
Cited by 4 | Viewed by 5483
Abstract
Acute Exacerbation of Chronic Obstructive Pulmonary Disease is a form of severe Acute Respiratory Failure (ARF) requiring Conventional Oxygen Therapy (COT) in the case of absence of acidosis or the application of Non-Invasive Ventilation (NIV) in case of respiratory acidosis. In the last [...] Read more.
Acute Exacerbation of Chronic Obstructive Pulmonary Disease is a form of severe Acute Respiratory Failure (ARF) requiring Conventional Oxygen Therapy (COT) in the case of absence of acidosis or the application of Non-Invasive Ventilation (NIV) in case of respiratory acidosis. In the last decade, High Flow through Nasal Cannula (HFNC) has been increasingly used, mainly in patients with hypoxemic ARF. However, some studies were also published in AECOPD patients, and some evidence emerged. In this review, after describing the mechanism underlying potential clinical benefits, we analyzed the possible clinical application of HFNC to AECOPD patients. In the case of respiratory acidosis, the gold-standard treatment remains NIV, supported by strong evidence in favor. However, HFNC may be considered as an alternative to NIV if the latter fails for intolerance. HFNC should also be considered and preferred to COT at NIV breaks and weaning. Finally, HFNC should also be preferred to COT as first-line oxygen treatment in AECOPD patients without respiratory acidosis. Full article
(This article belongs to the Special Issue Pulmonary and Critical Care Medicine)
Show Figures

Figure 1

Other

6 pages, 2000 KiB  
Case Report
Severe Recurrent COVID-Associated Pulmonary Aspergillosis: A Challenging Case
by Luigi Vetrugno, Gian Marco Anzellotti, Regina Frontera, Zoe Parinisi, Barbara Sessa, Cristian Deana and Salvatore Maurizio Maggiore
Healthcare 2022, 10(12), 2483; https://doi.org/10.3390/healthcare10122483 - 8 Dec 2022
Cited by 1 | Viewed by 1419
Abstract
We report a rare case of severe COVID-19-associated pulmonary aspergillosis presenting as invasive pulmonary aspergillosis and subsequently invasive tracheobronchial aspergillosis during hospitalization in a critically ill patient who developed a further Aspergillus infection after home discharge. He needed readmission to the ICU and [...] Read more.
We report a rare case of severe COVID-19-associated pulmonary aspergillosis presenting as invasive pulmonary aspergillosis and subsequently invasive tracheobronchial aspergillosis during hospitalization in a critically ill patient who developed a further Aspergillus infection after home discharge. He needed readmission to the ICU and mechanical ventilation. We therefore strongly encourage a high degree of attention to fungal complications, even after viral recovery and ICU discharge. Full article
(This article belongs to the Special Issue Pulmonary and Critical Care Medicine)
Show Figures

Figure 1

8 pages, 8413 KiB  
Case Report
Combination of Multidisciplinary Therapies Successfully Treated Refractory Ventricular Arrhythmia in a STEMI Patient: Case Report and Literature Review
by Nung-Sheng Lin, Yen-Yue Lin, Yung-Hsi Kao, Chih-Pin Chuu, Kuo-An Wu, Jenq-Shyong Chan and Po-Jen Hsiao
Healthcare 2022, 10(3), 507; https://doi.org/10.3390/healthcare10030507 - 10 Mar 2022
Cited by 2 | Viewed by 2663
Abstract
Ventricular fibrillation (VF) is a life-threatening cardiac arrhythmia that can lead to loss of cardiac function and sudden cardiac death. The most common cause of VF is ischemic cardiomyopathy, especially in the context of an acute coronary event. Prompt treatment with resuscitation and [...] Read more.
Ventricular fibrillation (VF) is a life-threatening cardiac arrhythmia that can lead to loss of cardiac function and sudden cardiac death. The most common cause of VF is ischemic cardiomyopathy, especially in the context of an acute coronary event. Prompt treatment with resuscitation and defibrillation can be lifesaving. Refractory VF, or pulseless ventricular tachycardia (pVT), refers to cases that do not respond to traditional advanced cardiac life-support (ACLS) measures, and it has a low survival rate. Some new life-saving interventions and novel techniques have been proposed as viable treatment options for patients presenting with refractory VF/pVT out-of-hospital cardiac arrest; these include extracorporeal membrane oxygenation (ECMO), esmolol, stellate ganglion block (SGB), and double sequential defibrillation (DSD). Recently, DSD has been discussed and used more frequently, but its survival rate is still not promising. We report a case of refractory VF caused by acute myocardial infarction that was treated with ACLS, DSD, ECMO, and cardiac catheterization in sequence, with a successful outcome. Full article
(This article belongs to the Special Issue Pulmonary and Critical Care Medicine)
Show Figures

Figure 1

Back to TopTop